ID   KPYM_PONAB              Reviewed;         531 AA.
AC   Q5NVN0; Q5R500;
DT   24-JAN-2006, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   02-DEC-2020, entry version 104.
DE   RecName: Full=Pyruvate kinase PKM;
DE            EC=2.7.1.40 {ECO:0000250|UniProtKB:P14618};
DE   AltName: Full=Pyruvate kinase muscle isozyme;
GN   Name=PKM; Synonyms=PKM2;
OS   Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Pongo.
OX   NCBI_TaxID=9601;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain cortex;
RG   The German cDNA consortium;
RL   Submitted (NOV-2004) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Glycolytic enzyme that catalyzes the transfer of a phosphoryl
CC       group from phosphoenolpyruvate (PEP) to ADP, generating ATP. The ratio
CC       between the highly active tetrameric form and nearly inactive dimeric
CC       form determines whether glucose carbons are channeled to biosynthetic
CC       processes or used for glycolytic ATP production. The transition between
CC       the 2 forms contributes to the control of glycolysis and is important
CC       for tumor cell proliferation and survival. In addition to its role in
CC       glycolysis, also regulates transcription. Stimulates POU5F1-mediated
CC       transcriptional activation (By similarity). Promotes in a STAT1-
CC       dependent manner, the expression of the immune checkpoint protein CD274
CC       in ARNTL/BMAL1-deficient macrophages. Also acts as a translation
CC       regulator for a subset of mRNAs, independently of its pyruvate kinase
CC       activity: associates with subpools of endoplasmic reticulum-associated
CC       ribosomes, binds directly to the mRNAs translated at the endoplasmic
CC       reticulum and promotes translation of these endoplasmic reticulum-
CC       destined mRNAs (By similarity). Plays a general role in caspase
CC       independent cell death of tumor cells (By similarity).
CC       {ECO:0000250|UniProtKB:P14618, ECO:0000250|UniProtKB:P52480}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + pyruvate = ADP + H(+) + phosphoenolpyruvate;
CC         Xref=Rhea:RHEA:18157, ChEBI:CHEBI:15361, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:58702, ChEBI:CHEBI:456216;
CC         EC=2.7.1.40; Evidence={ECO:0000250|UniProtKB:P14618};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:P14618};
CC   -!- COFACTOR:
CC       Name=K(+); Xref=ChEBI:CHEBI:29103;
CC         Evidence={ECO:0000250|UniProtKB:P14618};
CC   -!- ACTIVITY REGULATION: Allosterically activated by D-fructose 1,6-
CC       bisphosphate (FBP). Inhibited by oxalate and 3,3',5-triiodo-L-thyronine
CC       (T3). The activity of the tetrameric form is inhibited by PML.
CC       Selective binding to tyrosine-phosphorylated peptides releases the
CC       allosteric activator FBP, leading to inhibition of PKM enzymatic
CC       activity, this diverts glucose metabolites from energy production to
CC       anabolic processes when cells are stimulated by certain growth factors.
CC       Glycolytic flux are highly dependent on de novo biosynthesis of serine
CC       and glycine, and serine is a natural ligand and allosteric activator
CC       (By similarity). {ECO:0000250|UniProtKB:P14618}.
CC   -!- PATHWAY: Carbohydrate degradation; glycolysis; pyruvate from D-
CC       glyceraldehyde 3-phosphate: step 5/5.
CC   -!- SUBUNIT: Monomer and homotetramer. Exists as a monomer in the absence
CC       of fructose 1,6 bi-phosphate (FBP), and reversibly associates to form a
CC       homotetramer in the presence of FBP. The monomeric form binds T3.
CC       Tetramer formation induces pyruvate kinase activity. FBP stimulates the
CC       formation of tetramers from dimers. Interacts with HERC1, POU5F1 and
CC       PML. Interacts (isoform M2) with EGLN3; the interaction hydroxylates
CC       PKM under hypoxia and enhances binding to HIF1A. Interacts (isoform M2)
CC       with HIF1A; the interaction is enhanced by binding of EGLN3, promoting
CC       enhanced transcription activity under hypoxia (By similarity).
CC       Interacts (isoform M2, but not isoform M1) with TRIM35; this
CC       interaction prevents FGFR1-dependent tyrosine phosphorylation (By
CC       similarity). Interacts with JMJD8 (By similarity).
CC       {ECO:0000250|UniProtKB:P14618}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P14618}. Nucleus
CC       {ECO:0000250|UniProtKB:P14618}. Note=Translocates to the nucleus in
CC       response to different apoptotic stimuli. Nuclear translocation is
CC       sufficient to induce cell death that is caspase independent, isoform-
CC       specific and independent of its enzymatic activity.
CC       {ECO:0000250|UniProtKB:P14618}.
CC   -!- PTM: ISGylated. {ECO:0000250|UniProtKB:P14618}.
CC   -!- PTM: Acetylation at Lys-305 is stimulated by high glucose
CC       concentration, it decreases enzyme activity and promotes its lysosomal-
CC       dependent degradation via chaperone-mediated autophagy.
CC       {ECO:0000250|UniProtKB:P14618}.
CC   -!- MISCELLANEOUS: There are 4 isozymes of pyruvate kinase in mammals (L,
CC       R, M1, M2) encoded by 2 different genes: PKLR and PKM. The L and R
CC       isozymes are generated from the PKLR by differential splicing of RNA;
CC       the M1 and M2 forms are produced from the PKM gene by differential
CC       splicing. L type is major isozyme in the liver, R is found in red
CC       cells, M1 is the main form in muscle, heart and brain, and M2 is found
CC       in early fetal tissues as well as in most cancer cells.
CC   -!- SIMILARITY: Belongs to the pyruvate kinase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CR861086; CAH93166.1; -; mRNA.
DR   EMBL; CR925988; CAI29633.1; -; mRNA.
DR   RefSeq; NP_001127083.1; NM_001133611.1.
DR   SMR; Q5NVN0; -.
DR   STRING; 9601.ENSPPYP00000007498; -.
DR   PRIDE; Q5NVN0; -.
DR   GeneID; 100174114; -.
DR   KEGG; pon:100174114; -.
DR   CTD; 5315; -.
DR   eggNOG; KOG2323; Eukaryota.
DR   InParanoid; Q5NVN0; -.
DR   OrthoDB; 933620at2759; -.
DR   UniPathway; UPA00109; UER00188.
DR   Proteomes; UP000001595; Unplaced.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005791; C:rough endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016301; F:kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0003729; F:mRNA binding; ISS:UniProtKB.
DR   GO; GO:0030955; F:potassium ion binding; IEA:InterPro.
DR   GO; GO:0004743; F:pyruvate kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:2000767; P:positive regulation of cytoplasmic translation; ISS:UniProtKB.
DR   GO; GO:1903672; P:positive regulation of sprouting angiogenesis; ISS:UniProtKB.
DR   CDD; cd00288; Pyruvate_Kinase; 1.
DR   Gene3D; 2.40.33.10; -; 1.
DR   Gene3D; 3.20.20.60; -; 1.
DR   Gene3D; 3.40.1380.20; -; 1.
DR   InterPro; IPR001697; Pyr_Knase.
DR   InterPro; IPR015813; Pyrv/PenolPyrv_Kinase-like_dom.
DR   InterPro; IPR040442; Pyrv_Kinase-like_dom_sf.
DR   InterPro; IPR011037; Pyrv_Knase-like_insert_dom_sf.
DR   InterPro; IPR018209; Pyrv_Knase_AS.
DR   InterPro; IPR015793; Pyrv_Knase_brl.
DR   InterPro; IPR015795; Pyrv_Knase_C.
DR   InterPro; IPR036918; Pyrv_Knase_C_sf.
DR   InterPro; IPR015806; Pyrv_Knase_insert_dom_sf.
DR   PANTHER; PTHR11817; PTHR11817; 1.
DR   Pfam; PF00224; PK; 1.
DR   Pfam; PF02887; PK_C; 1.
DR   PRINTS; PR01050; PYRUVTKNASE.
DR   SUPFAM; SSF50800; SSF50800; 1.
DR   SUPFAM; SSF51621; SSF51621; 1.
DR   SUPFAM; SSF52935; SSF52935; 1.
DR   TIGRFAMs; TIGR01064; pyruv_kin; 1.
DR   PROSITE; PS00110; PYRUVATE_KINASE; 1.
PE   2: Evidence at transcript level;
KW   Acetylation; Allosteric enzyme; ATP-binding; Cytoplasm; Glycolysis;
KW   Isopeptide bond; Kinase; Magnesium; Metal-binding; Methylation;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Potassium; Pyruvate;
KW   Reference proteome; Transferase; Translation regulation; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P11979"
FT   CHAIN           2..531
FT                   /note="Pyruvate kinase PKM"
FT                   /id="PRO_0000112090"
FT   NP_BIND         75..78
FT                   /note="ATP"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   REGION          307..531
FT                   /note="Interaction with POU5F1"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   REGION          389..433
FT                   /note="Intersubunit contact"
FT   REGION          432..437
FT                   /note="D-fructose 1,6-bisphosphate binding; part of
FT                   allosteric site"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   REGION          516..521
FT                   /note="D-fructose 1,6-bisphosphate binding; part of
FT                   allosteric site"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   METAL           75
FT                   /note="Potassium"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   METAL           77
FT                   /note="Potassium"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   METAL           113
FT                   /note="Potassium"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   METAL           114
FT                   /note="Potassium; via carbonyl oxygen"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   METAL           272
FT                   /note="Magnesium"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   METAL           296
FT                   /note="Magnesium"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   BINDING         70
FT                   /note="Serine"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   BINDING         73
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P30613"
FT   BINDING         106
FT                   /note="Serine"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   BINDING         120
FT                   /note="ATP"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   BINDING         207
FT                   /note="ATP"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   BINDING         270
FT                   /note="Substrate; via amide nitrogen"
FT                   /evidence="ECO:0000250|UniProtKB:P30613"
FT   BINDING         295
FT                   /note="Substrate; via amide nitrogen"
FT                   /evidence="ECO:0000250|UniProtKB:P30613"
FT   BINDING         296
FT                   /note="Substrate; via amide nitrogen"
FT                   /evidence="ECO:0000250|UniProtKB:P30613"
FT   BINDING         328
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P30613"
FT   BINDING         464
FT                   /note="Serine"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   BINDING         482
FT                   /note="D-fructose 1,6-bisphosphate; part of allosteric
FT                   site"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   BINDING         489
FT                   /note="D-fructose 1,6-bisphosphate; part of allosteric
FT                   site"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   SITE            270
FT                   /note="Transition state stabilizer"
FT                   /evidence="ECO:0000250|UniProtKB:P00549"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11979"
FT   MOD_RES         3
FT                   /note="N6,N6,N6-trimethyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   MOD_RES         37
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   MOD_RES         41
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   MOD_RES         62
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   MOD_RES         66
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P52480"
FT   MOD_RES         89
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   MOD_RES         97
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11980"
FT   MOD_RES         100
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11980"
FT   MOD_RES         105
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   MOD_RES         127
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   MOD_RES         148
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P52480"
FT   MOD_RES         166
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   MOD_RES         166
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P52480"
FT   MOD_RES         175
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   MOD_RES         195
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   MOD_RES         266
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   MOD_RES         270
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P52480"
FT   MOD_RES         305
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   MOD_RES         322
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P52480"
FT   MOD_RES         322
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P52480"
FT   MOD_RES         475
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P52480"
FT   MOD_RES         498
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P52480"
FT   CROSSLNK        115
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   CROSSLNK        166
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   CROSSLNK        266
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   CROSSLNK        270
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P14618"
FT   CONFLICT        153
FT                   /note="D -> G (in Ref. 1; CAH93166)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        329
FT                   /note="Q -> R (in Ref. 1; CAH93166)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        347
FT                   /note="G -> D (in Ref. 1; CAH93166)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   531 AA;  58018 MW;  86BDD4AEF68B5510 CRC64;
     MSKPHSEAGT AFIQTQQLHA AMADTFLEHM CRLDIDSPPI TARNTGIICT IGPASRSVET
     LKEMIKSGMN VARLNFSHGT HEYHAETIKN VRTATESFAS DPILYRPVAV ALDTKGPEIR
     TGLIKGSGTA EVELKKGATL KITLDNAYME KCDENILWLD YKNICKVVEV GSKIYVDDGL
     ISLQVKQKGA DFLLTEVENG GSLGSKKGVN LPGAAVDLPA VSEKDIQDLK FGVEQDVDMV
     FASFIRKASD VHEVRKVLGE KGKNIKIISK IENHEGVRRF DEILEASDGI MVARGDLGIE
     IPAEKVFLAQ KMMIGRCNRA GKPVICATQM LESMIKKPRP TRAEGSGVAN AVLDGADCIM
     LSGETAKGDY PLEAVRMQHL IAREAEAAMF HRKLFEELVR ASSHSTDLME AMAMGSVEAS
     YKCLAAALIV LTESGRSAHQ VARYRPRAPI IAVTRNPQTA RQAHLYRGIF PVLCKDPVQE
     AWAEDVDLRV NFAMNVGKAR GFFKKGDVVI VLTGWRPGSG FTNTMRVVPV P
//
